You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

April 2002

Volume 53, Issue 4

Pages 341–448

  1. Review

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
  2. Pharmacokinetics

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
      The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide (pages 347–354)

      Richard T. Penson, Simon P. Joel, Michael Roberts, Anna Gloyne, Stephen Beckwith and Maurice L. Slevin

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01554.x

  3. Pharmacokinetics/pharmacodynamics

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
  4. Pharmacovigilance

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
      Association between antidepressant drug use and hyponatraemia: a case-control study (pages 363–369)

      Kris L. L. Movig, Hubert G. M. Leufkens, Albert W. Lenderink, Veronique G. A. Van Den Akker, Paul P. G. Hodiamont, Henk M. J. Goldschmidt and Antoine C. G. Egberts

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01550.x

    2. You have free access to this content
      Non-sedating antihistamine drugs and cardiac arrhythmias – biased risk estimates from spontaneous reporting systems? (pages 370–374)

      M. L. De Bruin, E. P. Van Puijenbroek, A. C. G. Egberts, A. W. Hoes and H. G. M. Leufkens

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01569.x

  5. Pharmacoepidemiology

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
      High persistence of statin use in a Danish population: Compliance study 1993–1998 (pages 375–378)

      John Larsen, Morten Andersen, Jakob Kragstrup and Lars F. Gram

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01563.x

    2. You have free access to this content
      Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated? (pages 379–385)

      Aukje K. Mantel-Teeuwisse, Olaf H. Klungel, W. M. Monique Verschuren, Arijan J. Porsius and Anthonius De Boer

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01562.x

  6. Short reports

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
      Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation (pages 386–389)

      Serge Cremers, Rik Schoemaker, Robbert Bredius, Jan Den Hartigh, Lynne Ball, Irene Twiss, Pieter Vermeij and Jaak Vossen

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01555.x

    2. You have free access to this content
      Pharmacokinetics and metabolism of oral midazolam in preterm infants (pages 390–392)

      S. N. De Wildt, G. L. Kearns, W. C. J. Hop, D. J. Murry, S. M. Abdel-Rahman and J. N. Van Den Anker

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01223.x

    3. You have free access to this content
      Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19 (pages 393–397)

      Joo-Youn Cho, Kyung-Sang Yu, In-Jin Jang, Byung-Hwan Yang, Sang-Goo Shin and Dong-Seok Yim

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01366.x

    4. You have free access to this content
      Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine (pages 398–402)

      S. O'Riordan, E. Ouldred, S. Brice, S. H. D. Jackson and C. G. Swift

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01549.x

  7. Letter to the Editors

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
      A possible interaction between lithium and rofecoxib (pages 403–404)

      Jöns Lundmark, Tove Gunnarsson and Finn Bengtsson

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01572_1.x

    2. You have free access to this content
    3. You have free access to this content
      Amlodipine and grapefruit juice (page 405)

      M. Josefsson and J. Ahlner

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01572_3.x

    4. You have free access to this content
      A reply: (pages 406–407)

      John Vincent, Stuart Harris, George Foulds, Lisa Dogolo, Susan Willavize and Hylar Friedman

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.15724.x

    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
      CYP2C9 polymorphism and warfarin dose requirements (pages 408–409)

      Ann K. Daly, Christopher P. Day and Guruprasad P. Aithal

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01572_6.x

    8. You have free access to this content
  8. Book review

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content
      Recombinant protein drugs (page 411)

      Peter Lewis

      Version of Record online: 28 APR 2002 | DOI: 10.1046/j.1365-2125.2002.01571.x

  9. Proceedings of the BPS

    1. Top of page
    2. Review
    3. Pharmacokinetics
    4. Pharmacokinetics/pharmacodynamics
    5. Pharmacovigilance
    6. Pharmacoepidemiology
    7. Short reports
    8. Letter to the Editors
    9. Book review
    10. Proceedings of the BPS
    1. You have free access to this content

SEARCH

SEARCH BY CITATION